[57] suggested that epigenetic downregulation of DDR2 in human‐derived bone marrow mesenchymal stem cells is associated with reduced proliferation and increased senescence of these cells, which is in agreement with our findings in SH‐SY5Y neuroblastoma cells. The gene discussed is DDR2; the disease is neuroblastoma.